CI

At a glance

ClinicalIndex Comparison Record
Phase 3Completed· 222 enrolled
Drug / intervention
000-0551 Lotion +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01882647
NCT01882647Phase 3Completed
CompareCT.gov

A Multicenter, Randomized, Double-Blind, Parallel Group Comparison of 000-0551 Lotion Versus Vehicle Lotion in Subjects With Plaque Psoriasis (Study -305)

Therapeutics, Inc.·interventional·Posted Jun 20, 2013·Updated Feb 13, 2017

In Brief

A Phase 3 clinical trial evaluating 000-0551 Lotion and Vehicle Lotion for Plaque Psoriasis. Completed, enrolled 222 participants across 11 sites.

Detailed Summary

This Phase 3 study has been designed to determine and compare the efficacy and safety of 000-0551 Lotion and Vehicle Lotion applied twice daily for two weeks in subjects with plaque psoriasis.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPlaque Psoriasis
CountriesUnited States
Collaborators--

Timeline

Phase 3CompletedFinished
2014201520162017201820192020202120222023202420252026
First PostedJun 20, 2013
Enrollment StartJun 1, 2013
Primary CompletionMar 1, 2014
TodayJul 2, 2026
Enrollment to primary: 9 monthsPosted 13.0 years ago

Interventions

000-0551 Lotiondrug

Vehicle Lotiondrug